Roderick H. MacLeod

CIK 1815111 · SVP, Chief Financial Officer · last filed 2025-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

28

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NEVRO CORP (NVRO) Delisted SVP, Chief Financial Officer 0 $5.84 $0 $0 28 2025-04-03

Recent Filings · Page 2 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-30 NEVRO CORP (NVRO) Delisted Tax (F) −816 -$7.8K EDGAR
2024-03-11 NEVRO CORP (NVRO) Delisted Mixed +77,190 -$109.3K EDGAR
2024-03-06 NEVRO CORP (NVRO) Delisted Mixed +305 -$6.4K EDGAR
2024-03-05 NEVRO CORP (NVRO) Delisted Tax (F) −1,270 -$18.1K EDGAR
2024-03-01 NEVRO CORP (NVRO) Delisted Tax (F) −898 -$13.3K EDGAR
2023-11-30 NEVRO CORP (NVRO) Delisted Tax (F) −800 -$13.3K EDGAR
2023-08-30 NEVRO CORP (NVRO) Delisted Tax (F) −800 -$15.5K EDGAR
2023-06-20 NEVRO CORP (NVRO) Delisted Tax (F) −1,585 -$39.6K EDGAR
2023-05-31 NEVRO CORP (NVRO) Delisted Tax (F) −800 -$21.2K EDGAR
2023-03-09 NEVRO CORP (NVRO) Delisted Grant (A) +39,282 $0 EDGAR
Showing 1120 of 28
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.